[go: up one dir, main page]

SE9401087D0 - New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension - Google Patents

New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Info

Publication number
SE9401087D0
SE9401087D0 SE9401087A SE9401087A SE9401087D0 SE 9401087 D0 SE9401087 D0 SE 9401087D0 SE 9401087 A SE9401087 A SE 9401087A SE 9401087 A SE9401087 A SE 9401087A SE 9401087 D0 SE9401087 D0 SE 9401087D0
Authority
SE
Sweden
Prior art keywords
glaucoma
treatment
ocular hypertension
prostaglandin derivatives
new prostaglandin
Prior art date
Application number
SE9401087A
Other languages
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9401087A priority Critical patent/SE9401087D0/en
Publication of SE9401087D0 publication Critical patent/SE9401087D0/en
Priority to PCT/SE1995/000347 priority patent/WO1995026729A1/en
Priority to AU21559/95A priority patent/AU2155995A/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Therapeutically active and physiologically acceptable 11-deoxy or 15-deoxy prostaglandin F2 alpha derivatives containing a ring substituted omega chain and their use for the preparation of compositions for the treatment of glaucoma or ocular hypertension.
SE9401087A 1994-03-31 1994-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension SE9401087D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9401087A SE9401087D0 (en) 1994-03-31 1994-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
PCT/SE1995/000347 WO1995026729A1 (en) 1994-03-31 1995-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU21559/95A AU2155995A (en) 1994-03-31 1995-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401087A SE9401087D0 (en) 1994-03-31 1994-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Publications (1)

Publication Number Publication Date
SE9401087D0 true SE9401087D0 (en) 1994-03-31

Family

ID=20393491

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401087A SE9401087D0 (en) 1994-03-31 1994-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Country Status (3)

Country Link
AU (1) AU2155995A (en)
SE (1) SE9401087D0 (en)
WO (1) WO1995026729A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
AU714272B2 (en) * 1995-12-22 1999-12-23 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US6353000B1 (en) * 1996-11-12 2002-03-05 Alcon Laboratories, Inc. 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
SE9900672D0 (en) 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP2628725A1 (en) 2005-11-03 2013-08-21 Allergan, Inc. Prostaglandins and analogues as agents for lowering intraocular pressure
WO2008073752A2 (en) * 2006-12-11 2008-06-19 Allergan, Inc. Cyclobutyl derivatives for the treatment of glaucoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029693A (en) * 1975-01-20 1977-06-14 The Upjohn Company 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
US4061670A (en) * 1976-07-19 1977-12-06 American Cyanamid Company 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners
GB1595998A (en) * 1977-03-30 1981-08-19 American Cyanamid Co Prostenoic acids and esters
DE03014533T1 (en) * 1988-09-06 2004-07-15 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DK0471856T3 (en) * 1990-03-08 1995-06-06 Shionogi & Co 15-deoxyprostaglandin derivatives

Also Published As

Publication number Publication date
AU2155995A (en) 1995-10-23
WO1995026729A1 (en) 1995-10-12

Similar Documents

Publication Publication Date Title
LU91541I2 (en) latanoprost and its pharmaceutically acceptable derivatives (XALATAN)
DK1514548T3 (en) Topical ophthalmic fluprostenol preparation for the treatment of glaucoma and ocular hypertension
ES2178291T3 (en) USE OF 3-BENZOIL-ACETIC, ESTER, OR AMIDAS ACIDS FOR THE TREATMENT OF GLCUCA GLAUCOMA.
BRPI0418245A (en) Nitroxy Prostaglandin Derivatives
SE8703854D0 (en) PROSTAGLAND INGREDIENTS FOR TREATMENT OF GLAUCOME OR OCULAR HYPERTENSION
MX9400037A (en) OPHTHALMIC COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND EYE HYPERTENSION.
SE0102055D0 (en) New Compounds
SE9401087D0 (en) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69834638D1 (en) HEALING COMPOSITION FOR INTRAOCULAR HYPERTENSION OR GLAUCOMA
DE69819539D1 (en) ANTITHROMBOTIC AGENTS
NO980058L (en) Ophthalmic preparations
EP0302757A3 (en) Anti-emetic serotonin depleting agents
ES2106852T3 (en) OPHTHALMIC COMPOSITION CONTAINING TIMOLOL HEMIHYDRATE.
TR199900013T2 (en) New bracelets.
DE69829227D1 (en) DRUG COMPOSITION FOR THE TREATMENT OF INCREASED EYE REMINDER OR GLAUCOMA
ATE268768T1 (en) ANTITHROMBOTIC AGENTS